Skip to main content
Premium Trial:

Request an Annual Quote

Cellumen Will Profile Environmental Chemicals for Toxins for EPA's Toxcast Program

NEW YORK (GenomeWeb News) — Cellumen will profile potentially toxic compounds for an Environmental Protection Agency program, the company said today.
 
Under the multi-year agreement with EPA’s Toxcast program, Cellumen said it will use its cytotoxicity profiling method to test chemicals that may be harmful to humans.
 
Toxcast aims to “better prioritize environmental chemicals while reducing costs and dependency on animal testing,” Kate Johnston, Cellumen’s vice president of Discovery Programs, said in a statement.
 
Cellumen said its profiling technique measures full-dose responses for 11 cellular parameters at three points, and produces 330 data points per compound.
 
Financial terms of the agreement were not disclosed.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.